Result of AGM

ValiRx PLC
27 July 2007

                                   ValiRx plc



                                (the 'Company')



                                 Result of AGM



The Company announces that all resolutions were duly approved at the annual
general meeting of the Company held earlier today, including the following
special resolutions:



  • that the authorised share capital of the company be increased to
    £15,491,726.61 by the creation of 50,000,000 ordinary shares of 0.2p each
    having the same rights in all respects as the existing ordinary shares in
    the capital of the Company;



  • that every thirty ordinary shares of 0.2p each in the capital of the
    Company be consolidated into one ordinary share of 6p, each having the same
    rights in all respects ('Capital Reorganisation');



  • to authorise the directors, generally and unconditionally for the purpose
    of Section 80 of the Companies Act 1985 ('the Act'), to allot relevant
    securities  up to a maximum aggregate nominal amount of £1,000,000;



  • the directors be and they are hereby empowered, pursuant to Section 95 of
    the Act, to allot equity securities wholly for cash pursuant to the
    authority conferred by the previous resolution as if Section 89(1) of the
    Act did not apply to such allotment PROVIDED THAT this power shall be
    limited to the allotment of equity securities:



(a) in connection with an offer of such securities by way of rights to holders
of ordinary shares in proportion (as nearly as may be practicable) to their
respective holdings of such shares, but subject to such exclusions or other
arrangements as the directors may deem necessary or expedient in relation to
fractional entitlements or any legal or practical problems under the laws of any
territory, or the requirements of any regulatory body or stock exchange; and

(b) otherwise than pursuant to sub-paragraph (a) above up to an aggregate
nominal amount of £355,000;



  • that all the issued and unissued deferred shares of 0.9p each in the
    capital of the Company and all the issued and unissued deferred shares of
    99p each in the capital of the Company be cancelled and the share premium
    account of the Company be cancelled.



Pursuant to the Capital Reorganisation, the Company has applied for 29,553,047
ordinary shares of 6p each to be admitted to trading on AIM and dealings are
expected to commence at 8.00 a.m. on 31 July 2007. Trading in the Company's
existing 886,591,389 ordinary shares of 0.2p each will therefore cease at 4.30
p.m. on 30 July 2007.



For further information please contact:


        ValiRx plc                    WH Ireland                      GTH Communications
     Dr Satu Vainikka               David Youngman               Toby Hall / Jade Mamarbachi
   [phone]          [phone]                [phone]




                      This information is provided by RNS
            The company news service from the London Stock Exchange                  EEW